Lung Cancer
News
Drug combo broke through drug resistance in some patients with advanced lung cancer
Key clinical point: Patients with advanced lung cancers that have become resistant to erlotinib or gefitinib may benefit from combination therapy...
News
Study backs thoracic radiation in extensive small-cell lung cancer
Key clinical point: Thoracic radiotherapy may improve survival when delivered after chemotherapy in extensive-stage lung cancer responding to...
News
Anatomic segmentectomy as good as lobectomy
Major finding: Overall survival was 54% for anatomic segmentectomy and 60% for lobectomy, a nonsignificant difference; both locoregional...
News
Panel recommends against low-dose CT for lung cancer in Medicare patients
News
Second ALK tyrosine kinase inhibitor approved for late-stage lung cancer
News
High tobacco use in subpopulations of Americans and rapid uptake in other countries are major concerns
News
Medicare asks experts to weigh in on low-dose CT lung cancer screening
News
Phase III trial of PARP inhibitor for lung cancer launches
Conference Coverage
Cloud of questions hovers around electronic cigarettes
News
Conventional chemo bests tyrosine kinase inhibitors in wild-type lung cancers
Key clinical point: Major finding: Progression-free survival was significantly longer with conventional chemotherapy than with EGFR tyrosine...